Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Wegman currently holds 947,473 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Wegman has been a net seller of BSTC stock. They have purchased $0 and sold $32.0M worth of shares.
Thomas Wegman's most recent insider trade was on Aug 17, 2018, when they sold 2,500 shares at $51.89 per share.
Thomas Wegman serves as Executive at BIOSPECIFICS TECHNOLOGIES CORP (BSTC). They have executed 66 insider transactions totaling $32.0M over their tenure at the company.
Thomas Wegman holds the position of Executive at BIOSPECIFICS TECHNOLOGIES CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Thomas Wegman has shown a selling trading pattern, with $0 in total purchases and $32.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Wegman was on Sep 13, 2010, when they sold $3.5M worth of BSTC shares. This transaction involved 150,000 shares at $23.50 per share.
Thomas Wegman currently owns 947,473 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Wegman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Wegman has 66 Form 4 filings on record as an insider at BIOSPECIFICS TECHNOLOGIES CORP.
Set alerts for Thomas Wegman and 40,000+ other insiders.